Indivior Pharmaceuticals Inc (INDV.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.69B |
| Enterprise Value | 1.75B |
| P/E Ratio | 12.15 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 3.23 |
| Price/Book Ratio | -20.8 |
| Enterprise/Revenue | 3.45 |
| Enterprise/EBITDA | 10.63 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.39 |
AD
Management Effectiveness
| Return On Assets | 0.29 |
| Return On Equity | -2.16 |
Income Statement
| Revenue | 1.19B |
| Revenue/Share | 10.63 |
| Gross Profit | 957M |
| EBITDA | 84M |
| Net Income | 2M |
| Diluted EPS | 0.02 |
Balance Sheet
| Total Cash | 510M |
| Total Cash/Share | 1.77 |
| Total Debt | 366M |
| Total Debt/Equity | -2.45 |
| Current Ratio | 0.84 |
| Book Value Per Share | -1.66 |
Price History
| 52-Week Change | 33.84 |
| 52-Week High | 1,264 |
| 52-Week Low | 548.71 |
| Moving Average 50 Days | 1,021.29 |
| Moving Average 200 Days | 867.57 |
Statistics
| Average Volume | 304,326 |
| Shares Outstanding | 124.77M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | October 10, 2022 |
AD
